论文部分内容阅读
临床荟萃(1993;8(14):657)刊登了《654-2治疗过敏性休克》一文,笔者对此进行了验证,疗效可靠,总结如下。 1 临床资料 1.1 一般资料 收集门诊及病房18例。病因为低分子右旋糖酐过敏者4例,青霉素过敏者2例,普鲁卡因过敏者2例,细胞色素过敏者4例,蝮蛇抗栓酶过敏者2例,其余4例均为联合用药输液引起过敏反应。原发病为慢性支气管炎6例,脑梗塞4例,急性扁桃体炎3例,急性胃粘膜病变3例,冠心病2例。这些病例均符合实用内科学过敏性休克诊断标准。 1.2 治疗方法 患者一旦出现过敏性休克症状,立即停输原来的液体,常规吸氧,迅速静脉推注“654-2”15～20mg,15～20分钟症状不缓解,血压未回升者,加地塞米松10mg静脉推注。
Clinical Metabolism (1993; 8 (14): 657) published a “654-2 treatment of anaphylactic shock,” a text that I verified, reliable, summarized as follows. 1 clinical data 1.1 general information collection outpatient and ward in 18 cases. 4 cases of low molecular dextran allergy, 2 cases of penicillin allergy, 2 cases of procaine allergy, 4 cases of cytochrome allergy, viper antithrombotic enzyme allergy in 2 cases, the remaining 4 cases were combined with infusion Cause an allergic reaction. The primary disease was chronic bronchitis in 6 cases, 4 cases of cerebral infarction, acute tonsillitis in 3 cases, acute gastric mucosal lesions in 3 cases, 2 cases of coronary heart disease. These cases are in line with practical diagnostic criteria for anaphylactic shock. 1.2 treatment of patients in the event of anaphylactic shock symptoms, immediately stop the original liquid, conventional oxygen, rapid intravenous bolus “654-2” 15 ~ 20mg, 15 to 20 minutes the symptoms do not ease, blood pressure did not rise those who add dexamethasone Mesh 10mg intravenous injection.